AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bittium Oyj

Director's Dealing May 19, 2025

3258_rns_2025-05-19_a5db9a10-dbd9-4458-becc-846eaef71678.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Bittium Corporation - Managers' Transactions - Petri Toljamo

Bittium Corporation - Managers' Transactions - Petri Toljamo

Bittium Corporation
Managers' Transactions

Bittium Corporation - Managers' Transactions - Petri Toljamo

Bittium Corporation, Stock Exchange Release, May 19, 2025, at 3:15 pm (CEST+1)

Person subject to the notification requirement

Name: Petri Toljamo

Position: Chief Executive Officer

Issuer: Bittium Oyj

LEI: 743700NFG5W5I59OVX65

Notification type: INITIAL NOTIFICATION

Reference number: 108905/4/4

Transaction date: 2025-05-15

Outside a trading venue

Instrument type: SHARE

ISIN: FI0009007264

Nature of transaction: SUBSCRIPTION

Transaction details

(1): Volume: 14949 Unit price: 6.69 EUR

Aggregated transactions (1):

Volume: 14949 Volume weighted average price: 6.69 EUR

Oulu, May 19, 2025

Bittium Corporation

Further information:

Karoliina Malmi
Vice President, Communications and Sustainability
Tel. +358 40 344 2789

Distribution

Nasdaq Helsinki Oy
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and
connectivity solutions leveraging its 40-year legacy of expertise in advanced
radio communication technologies. Bittium provides innovative products and
services, customized solutions based on its product platforms and R&D services.
Complementing its communications and connectivity solutions, Bittium offers
proven information security solutions for mobile devices and portable computers.
Bittium also provides healthcare technology products and services for biosignal
measuring in the areas of cardiology and neurophysiology. Net sales in 2024 were
EUR 85.2 million and operating profit was EUR 8.6 million. Bittium is listed on
Nasdaq Helsinki. www.bittium.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.